Pricing

Q32 Bio Inc. (QTTB)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Albert Seymour
Employees:
220
ONE PATRIOTS PARK, BEDFORD, MA, 01730
781-301-7277
Stock Split History
DateRatio
2024-03-26 1:18
Homology Medicines, Inc. focuses on transforming the lives of patients suffering from rare genetic diseases. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available